Rock Springs Capital Management LP Fibrogen Inc Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $3.18 Million - $8.33 Million	-312,687 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $102,300 - $183,876	3,300 Added 1.07%	312,687 $10.9 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $3,709 - $4,897	100 Added 0.03%	309,387 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $249,376 - $280,371	-6,162 Reduced 1.95%	309,287 $12.7 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $307,753 - $404,700	9,449 Added 3.09%	315,449 $12.8 Million
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $56,300 - $67,250	-1,000 Reduced 0.33%	306,000 $18.6 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $112,250 - $162,375	-2,500 Reduced 0.81%	307,000 $19.2 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $702,925 - $955,575	-15,500 Reduced 4.77%	309,500 $14.3 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $10.9 Million - $17.5 Million	325,000	325,000 $17.5 Million

115

57.5M

2.14M

907K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $38.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.